Indications of an ongoing shift within healthcare and society more broadly, which include the American Medical Associations recognition of obesity as a disease in 2013, signal a trend towards a more nuanced understanding of the multifactorial nature of the disease, reducing blame and stigmatization and opening doors for greater investment in therapy, including new medications like GLP-1 agonists
Wang M, Geng X, Li K, Wang Y, Duan X, Hou C, et al
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes mellitus, though they have gained considerable attention for their weight loss effects
How long does the article say the common opening-week side effects usually last
1994;266:E17985
If diarrhea is your main issue, this may help too: GLP-1 diarrhea food reset